Clearstead Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$477K Buy
987
+4
+0.4% +$1.06K ﹤0.01% 778
2026
Q1
$108K Buy
983
+313
+47% +$44.6K ﹤0.01% 1124
2025
Q4
$111K Buy
670
+34
+5% +$5.69K ﹤0.01% 1097
2025
Q3
$125K Buy
636
+76
+14% +$12.5K ﹤0.01% 995
2025
Q2
$50.6K Buy
560
+8
+1% +$632 ﹤0.01% 1290
2025
Q1
$32.9K Buy
552
+202
+58% +$18.7K ﹤0.01% 1280
2024
Q4
$46.4K Sell
350
-910
-72% -$85.4K ﹤0.01% 1178
2024
Q3
$66K Buy
+1,260
New +$59.1K ﹤0.01% 1142

Other funds holding ALAB

Clearstead Advisors's ALAB Position: Q2 2026 in Review

Clearstead Advisors increased its Astera Labs (ALAB) stake by 0.41% in Q2 2026, buying an estimated $1.06K and bringing the position to 987 shares worth $477K. The position accounts for ﹤0.01% of the portfolio, ranked #778.

Clearstead Advisors first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Clearstead Advisors held 987 shares of Astera Labs worth $477K as of Q2 2026.
  • Clearstead Advisors bought 4 Astera Labs shares in Q2 2026, an estimated $1.06K.
  • Astera Labs made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #778 holding.
  • Clearstead Advisors first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.